gastroparesis and glp-1 (Stomach Paralysis): Symptoms; Risks Can GLP1 receptor agonists cause

dAquino AI, Maikawa CL, Nguyen LT, et al

Your healthcare provider will likely start you on a low dose of semaglutide and gradually increase it to minimize side effects and help your body adjust to the medication

Key tips for underwriting applicants with GLP1 use Immediately look for: Evidence of the underlying diagnosis (as seen in medical claims, EHR, APS) Whether the GLP-1 is FDA-approved or off-label for that condition Signs of medication adherence (12 months, regular fills) Get cautious when: A GLP1 appears without any supporting clinical context Fills are intermittent or recently initiated Theres no alignment between the medication and expected companion therapies (e.g., no CPAP with sleep apnea) Be confident when: The diagnosis is clear The drug is first line and clinically appropriate Use has been stable long enough to confer benefit Kyle Schimek, PharmD Kyle Schimek is a board-certified pharmacist and Clinical Services Manager at Milliman IntelliScript

Am Health Drug Benefits 6 , 423430 (2013)

Fibre supplementation has more consistent, though modest, evidence

Describes studies on GLP-1 medication users, not specific product claims